T0	KEYPHRASE-NOTYPES 16 24	duration,"the","of "
T1	KEYPHRASE-NOTYPES 28 31	FNP," of","wit"
T2	KEYPHRASE-NOTYPES 37 39	LD,"ith","is "
T3	KEYPHRASE-NOTYPES 76 88	causes,"ith","of "
T4	KEYPHRASE-NOTYPES 92 106	peripheral FNP," of"," [1"
T5	KEYPHRASE-NOTYPES 116 126	Resolution,"15]","may"
T6	KEYPHRASE-NOTYPES 159 168	treatment,"ing"," an"
T7	KEYPHRASE-NOTYPES 174 191	overall prognosis,"and","is "
T8	KEYPHRASE-NOTYPES 231 247	several patients,"ote","who"
T9	KEYPHRASE-NOTYPES 256 259	FNP,"had","las"
T10	KEYPHRASE-NOTYPES 268 279	many months,"ing","eve"
T11	KEYPHRASE-NOTYPES 291 314	intravenous ceftriaxone,"ter","\nT"
T12	KEYPHRASE-NOTYPES 316 341	nThe laboratory diagnosis,"ne.","of "
T13	KEYPHRASE-NOTYPES 345 347	LD," of","can"
T14	KEYPHRASE-NOTYPES 366 397	Erythrocyte sedimentation rates,"lt."," wh"
T15	KEYPHRASE-NOTYPES 432 453	Cerebral spinal fluid,"ic.","(CS"
T16	KEYPHRASE-NOTYPES 455 458	CSF,"id "," ly"
T17	KEYPHRASE-NOTYPES 460 473	lymphocytosis,"SF)","and"
T18	KEYPHRASE-NOTYPES 478 499	elevated CSF proteins,"and","can"
T19	KEYPHRASE-NOTYPES 515 531	viral meningitis," in","as "
T20	KEYPHRASE-NOTYPES 543 545	LD," as"," Al"
T21	KEYPHRASE-NOTYPES 556 579	specific antibody tests,"ugh","may"
T22	KEYPHRASE-NOTYPES 602 610	early LD," in"," th"
T23	KEYPHRASE-NOTYPES 616 619	IgM,"the","may"
T24	KEYPHRASE-NOTYPES 651 656	weeks,"o 4","and"
T25	KEYPHRASE-NOTYPES 665 668	IgG,"the","may"
T26	KEYPHRASE-NOTYPES 700 705	weeks,"o 8"," [1"
